Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone dose adjustment guided by plasma R-methadone levels in opioid addiction
2008-005028-10Phase 4Completed
- Sponsor
- Università degli Studi di Firenze
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methadone in opioid use disorder (OUD) and heroin addiction (2 arms), sponsored by Università degli Studi di Firenze. Primary endpoints: Treatment retention at 12 months, Urine positivity for illicit drugs and 1 more. Started Oct 2008; status: completed.
02
Drugs
methadone
03
Conditions
opioid use disorder (OUD)heroin addiction
Beyond the preview
Go deeper on 2008-005028-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005028-10.